当前位置:首页 - 行情中心 - 悦康药业(688658) - 财务分析 - 现金流量表

悦康药业

(688658)

  

流通市值:83.97亿  总市值:83.97亿
流通股本:4.50亿   总股本:4.50亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金590,058,926.32,765,240,304.62,002,252,209.141,385,776,592.31
  收到的税费返还26,736,747.7334,881,264.446,959,117.175,493,803.36
  收到其他与经营活动有关的现金8,073,438250,546,825.2890,467,494.8582,900,935.4
  经营活动现金流入小计624,869,112.033,050,668,394.322,099,678,821.161,474,171,331.07
  购买商品、接受劳务支付的现金166,861,367.4785,973,168.51571,785,809.04433,501,407.03
  支付给职工以及为职工支付的现金114,782,275.82429,883,959.77328,971,560.91225,969,206.86
  支付的各项税费59,765,336.34222,789,143.75150,691,224.29101,684,294.76
  支付其他与经营活动有关的现金238,989,881.471,271,735,557.87879,895,937.34720,238,872.42
  经营活动现金流出小计580,398,861.032,710,381,829.91,931,344,531.581,481,393,781.07
  经营活动产生的现金流量净额44,470,251340,286,564.42168,334,289.58-7,222,450
二、投资活动产生的现金流量:
  收回投资收到的现金292,000,000620,000,000310,000,000190,000,000
  取得投资收益收到的现金1,115,315.683,716,129.192,153,787.031,658,444.41
  处置固定资产、无形资产和其他长期资产收回的现金净额-411,135.15107,623.28848.5
  收到的其他与投资活动有关的现金-10,290,706.1410,072,191.7872,191.78
  投资活动现金流入小计293,115,315.68634,417,970.48322,333,602.09191,731,484.69
  购建固定资产、无形资产和其他长期资产支付的现金26,163,920.17135,080,502.09116,921,992.4184,903,020.93
  投资支付的现金505,666,500969,000,000607,000,000360,000,000
  投资活动现金流出小计531,830,420.171,104,080,502.09723,921,992.41444,903,020.93
  投资活动产生的现金流量净额-238,715,104.49-469,662,531.61-401,588,390.32-253,171,536.24
三、筹资活动产生的现金流量:
  吸收投资收到的现金-100,000100,000-
  其中:子公司吸收少数股东投资收到的现金-100,000--
  取得借款收到的现金469,000,000122,523,831.62128,588,063.9128,588,063.9
  收到其他与筹资活动有关的现金20,500,000---
  筹资活动现金流入小计489,500,000122,623,831.62128,688,063.9128,588,063.9
  偿还债务支付的现金476,840,000203,119,432.5464,454,741.0243,262,041.02
  分配股利、利润或偿付利息支付的现金4,797,359.8423,242,760.0114,854,094.619,786,823.95
  支付其他与筹资活动有关的现金1,355,144.018,316,156.7372,695,116.5471,535,122.54
  筹资活动现金流出小计482,992,503.85234,678,349.28152,003,952.17124,583,987.51
  筹资活动产生的现金流量净额6,507,496.15-112,054,517.66-23,315,888.274,004,076.39
四、汇率变动对现金及现金等价物的影响-64,600.84137,936.78169,760.33107,617.23
五、现金及现金等价物净增加额-187,801,958.18-241,292,548.07-256,400,228.68-256,282,292.62
  加:期初现金及现金等价物余额996,526,592.731,237,819,140.81,237,819,140.81,237,819,140.8
  期末现金及现金等价物余额808,724,634.55996,526,592.73981,418,912.12981,536,848.18
补充资料:
  净利润--274,816,190.81--102,180,151.14
  资产减值准备-41,543,453.77-18,583,861.35
  固定资产和投资性房地产折旧-172,979,861.81-88,571,446.89
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-172,979,861.81-88,571,446.89
  无形资产摊销-27,927,366.16-13,579,767.71
  长期待摊费用摊销-4,974,805.2-2,315,152.5
  处置固定资产、无形资产和其他长期资产的损失--924,147.58--
  固定资产报废损失-2,462,357.76-49,686.11
  公允价值变动损失--6,040,391.9--
  财务费用-21,274,333.28-11,047,688.87
  投资损失--3,461,129.19--1,385,511.85
  递延所得税-32,580,588.91--1,855,297.92
  其中:递延所得税资产减少-25,485,671.53--1,855,297.92
    递延所得税负债增加-7,094,917.38--
  存货的减少-266,707,678.3-159,885,223.75
  经营性应收项目的减少-208,186,369.86-134,209,866.78
  经营性应付项目的增加--156,762,709.91--335,048,781.15
  现金的期末余额-996,526,592.73-981,536,848.18
  减:现金的期初余额-1,237,819,140.8-1,237,819,140.8
  现金及现金等价物的净增加额--241,292,548.07--256,282,292.62
公告日期2026-04-302026-03-212025-10-302025-08-29
审计意见(境内)标准无保留意见
TOP↑